Berberine Alleviates Amyloid β-Induced Mitochondrial Dysfunction and Synaptic Loss

Area of Science:

• Neuroscience
• Pharmacology
• Cell Biology

Background:

• Alzheimer's disease (AD) is characterized by synaptic damage, with amyloid-beta (Aβ) accumulation targeting mitochondria.
• Mitochondrial dysfunction and impaired axonal transport are critical in AD pathogenesis, affecting synaptic plasticity and neuronal function.

Purpose of the Study:

• To investigate the neuroprotective effects of berberine against Aβ-induced mitochondrial and synaptic damage in primary hippocampal neurons.
• To evaluate berberine's impact on mitochondrial function, axonal transport, and synaptic integrity in an AD model.

Main Methods:

• Primary hippocampal neurons were cultured and treated with amyloid-beta (Aβ) to induce damage.
• Berberine's effects on mitochondrial membrane potential, ATP levels, mitochondrial density, length, motility, and trafficking were assessed.
• Antioxidant activity of berberine was considered as a potential protective mechanism.

Main Results:

• Berberine treatment alleviated Aβ-induced axonal mitochondrial abnormalities.
• It preserved mitochondrial membrane potential and ATP levels, crucial for neuronal energy.
• Berberine enhanced mitochondrial density, length, motility, and trafficking in neurons exposed to Aβ.

Conclusions:

• Berberine demonstrates significant neuroprotective and mitoprotective effects against Aβ-induced synaptic damage.
• The findings suggest berberine's potential as a therapeutic agent for Alzheimer's disease, particularly by targeting mitochondrial dysfunction.
• Berberine's antioxidant properties likely contribute to its protective mechanisms, warranting further investigation.